Department of Neurology, Columbia University, New York, New York, USA.
Mov Disord. 2010;25 Suppl 1:S40-3. doi: 10.1002/mds.22717.
Parkinson's disease (PD) is typically a sporadic illness, but the past decade has witnessed the identification of mutations responsible for multiple familial forms of the disease. The proposed functions of some of these genes (e.g., E3 ubiquitin ligase, redox-dependent chaperone) have led to the hypothesis that dysfunction of protein quality control pathways contributes to PD neurodegeneration. However, the key signaling events that act downstream of misfolded proteins to cause cell death remain poorly defined. The discovery of the familial PD kinase leucine-rich repeat kinase 2 (LRRK2) holds great promise for the elucidation of signaling events relevant to PD neurodegeneration. This review will summarize current knowledge of the clinical and cell biological features of LRRK2, the most common inherited cause of Parkinsonism.
帕金森病(PD)通常是一种散发性疾病,但在过去的十年中,已经确定了导致多种家族形式的疾病的突变。这些基因的一些功能(例如,E3 泛素连接酶,依赖氧化还原的伴侣)已导致蛋白质量控制途径的功能障碍导致 PD 神经退行性变的假说。然而,导致细胞死亡的折叠错误蛋白下游的关键信号事件仍定义不清。家族性帕金森病激酶富亮氨酸重复激酶 2(LRRK2)的发现为阐明与 PD 神经退行性变相关的信号事件带来了巨大的希望。本综述将总结 LRRK2 的临床和细胞生物学特征的最新知识,LRRK2 是帕金森病最常见的遗传性病因。